Ozempic is a brand name semaglutide, a medication used to treat type 2 diabetes. It’s also used as an off-label use for weight loss. Wegovy is another brand name with the same a ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Although it is best known for treating type 2 diabetes, semaglutide — known by its brandname Ozempic — may also be effective ...

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose ...

My doctor increased my dose to 1.7 mg of Wegovy instead of 2 mg of Ozempic. I find myself continuing to crave sweets and have gained 8 pounds in around six months. I’m wondering if any studies explain ...

Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity. Both are made by Novo Nordisk. Eli Lilly also offers a diabetes medication, Mounjaro ...

Obese adults who took the weekly injection lost up to 22% of their starting weight after 11 months — compared to just 14% over 15 months for semaglutide, the active ingredient in Ozempic and Wegovy.

Specifically, the drug treats blood sugar in Type 2 diabetics. However, take a look at any public discussion around it, and the primacy of weight loss is clear. Ozempic itself is a metonym for ...

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

For example, some insurance covers Ozempic for prediabetes, and other times insurance will only cover Ozempic if you already have Type 2 diabetes. Ozempic is more likely to be covered by insurance if ...